Key Details
Price
$32.89Annual ROE
-36.38%Beta
2.07Events Calendar
Next earnings date:
May 2, 2025Recent quarterly earnings:
Feb 27, 2025Recent annual earnings:
Feb 27, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 28, 25 HC Wainwright & Co.
BuyJan 21, 25 Stephens & Co.
OverweightDec 27, 24 Leerink Partners
OutperformDec 10, 24 BTIG
BuyDec 6, 24 BMO Capital
Market PerformDec 2, 24 Wells Fargo
OverweightNov 18, 24 Stephens & Co.
OverweightNov 6, 24 Morgan Stanley
Equal-WeightNov 4, 24 UBS
BuyNov 1, 24 Truist Securities
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Kymera Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Kymera Therapeutics?
- Does Kymera Therapeutics pay dividends?
- What sector is Kymera Therapeutics in?
- What industry is Kymera Therapeutics in?
- What country is Kymera Therapeutics based in?
- When did Kymera Therapeutics go public?
- Is Kymera Therapeutics in the S&P 500?
- Is Kymera Therapeutics in the NASDAQ 100?
- Is Kymera Therapeutics in the Dow Jones?
- When was Kymera Therapeutics's last earnings report?
- When does Kymera Therapeutics report earnings?
- Should I buy Kymera Therapeutics stock now?
What is the ticker symbol for Kymera Therapeutics?
The ticker symbol for Kymera Therapeutics is NASDAQ:KYMR
Does Kymera Therapeutics pay dividends?
No, Kymera Therapeutics does not pay dividends
What sector is Kymera Therapeutics in?
Kymera Therapeutics is in the Healthcare sector
What industry is Kymera Therapeutics in?
Kymera Therapeutics is in the Biotechnology industry
What country is Kymera Therapeutics based in?
Kymera Therapeutics is headquartered in United States
When did Kymera Therapeutics go public?
Kymera Therapeutics's initial public offering (IPO) was on August 21, 2020
Is Kymera Therapeutics in the S&P 500?
No, Kymera Therapeutics is not included in the S&P 500 index
Is Kymera Therapeutics in the NASDAQ 100?
No, Kymera Therapeutics is not included in the NASDAQ 100 index
Is Kymera Therapeutics in the Dow Jones?
No, Kymera Therapeutics is not included in the Dow Jones index
When was Kymera Therapeutics's last earnings report?
Kymera Therapeutics's most recent earnings report was on Feb 27, 2025
When does Kymera Therapeutics report earnings?
The next expected earnings date for Kymera Therapeutics is May 2, 2025
Should I buy Kymera Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions